Comerica Bank cut its stake in shares of Pfizer Inc. (NYSE:PFE – Free Report) by 4.9% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 2,008,082 shares of the biopharmaceutical company’s stock after selling 102,459 shares during the period. Comerica Bank’s holdings in Pfizer were […]
Fort Sheridan Advisors LLC lessened its holdings in shares of Pfizer Inc. (NYSE:PFE – Free Report) by 23.1% during the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 81,157 shares of the biopharmaceutical company’s stock after selling 24,432 shares during the period. Fort Sheridan Advisors LLC’s holdings in Pfizer […]
New England Asset Management Inc. boosted its stake in shares of Pfizer Inc. (NYSE:PFE – Free Report) by 1.6% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 170,098 shares of the biopharmaceutical company’s stock after purchasing an additional 2,743 shares during the quarter. […]
Mmbg Investment Advisors CO. grew its position in Pfizer Inc. (NYSE:PFE – Free Report) by 13.5% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 157,855 shares of the biopharmaceutical company’s stock after purchasing an additional 18,730 shares during the period. Mmbg […]
Personal CFO Solutions LLC boosted its position in Pfizer Inc. (NYSE:PFE – Free Report) by 8.1% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 74,118 shares of the biopharmaceutical company’s stock after buying an additional 5,545 shares during the period. Personal […]
Personal CFO Solutions LLC boosted its holdings in shares of Pfizer Inc. (NYSE:PFE – Free Report) by 8.1% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 74,118 shares of the biopharmaceutical company’s stock after purchasing an additional 5,545 shares during […]
Prudential PLC lessened its position in Pfizer Inc. (NYSE:PFE – Free Report) by 33.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 331,548 shares of the biopharmaceutical company’s stock after selling 164,538 shares during the period. Prudential PLC’s […]
Bollard Group LLC lessened its position in Pfizer Inc. (NYSE:PFE – Free Report) by 4.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 75,089 shares of the biopharmaceutical company’s stock after selling 3,640 shares during the period. Bollard […]
Shepherd Financial Partners LLC cut its holdings in Pfizer Inc. (NYSE:PFE – Free Report) by 51.8% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 36,675 shares of the biopharmaceutical company’s stock after selling 39,344 shares during the period. Shepherd Financial Partners LLC’s […]
The Manufacturers Life Insurance Company boosted its holdings in Pfizer Inc. (NYSE:PFE – Free Report) by 0.1% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 5,654,953 shares of the biopharmaceutical company’s stock after purchasing an additional 4,568 shares during the quarter. The Manufacturers Life […]